Niihara Y, Miller ST, Kanter J, Lanzkron S, Smith WR, Hsu LL, Gordeuk VR, Viswanathan K, Sarnaik S, Osunkwo I, Guillaume E (2018) A phase 3 trial of L-glutamine in sickle cell disease
The most dramatic weight loss usually happens between months 3-8 as doses escalate
Clinical Management of Gastrointestinal Side Effects GI side effects associated with GLP-1 RAs can be effectively managed with patient-centred strategies
Glucose can diffuse directly into the mitochondria, so the oxidation of glucose is limited only by the biochemical reactions inside the mitochondria
Routine calcitonin measurement or thyroid ultrasound screening is not recommended solely based on GLP-1 use
For example, an 8-week study of 38 women found no difference between those who took L-carnitine and those who didnt when combined with equal exercise for both groups